1-4 of 4
Michael Unterhalt, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Combined Molecular and Clinical Prognostic Index For Relapse and Survival In Cytogenetically Normal AML (PINA)

Friederike Pastore, MD, Annika Dufour, PhD, Tobias Benthaus, MD, Klaus H. Metzeler, MD, Kati Maharry, MAS, Stephanie Schneider, PhD, Bianka Ksienzyk, Gudrun Mellert, Evelyn Zellmeier, Purvi M. Kakadia, PhD, Michael Unterhalt, M.D. Ph.D., Michaela Feuring-Buske, MD, Christian Buske, MD, Jan Braess, MD, Cristina Sauerland, MSc, Achim Heinecke, PhD, Utz Krug, MD, Wolfgang E. Berdel, MD, Thomas Büchner, MD, Bernhard J. Woermann, MD, Wolfgang Hiddemann, MD, Stefan K. Bohlander, MD, Guido Marcucci, MD, Karsten Spiekermann, MD, Clara D. Bloomfield, MD, Eva Hoster, PhD
Journal: Blood
Blood (2013) 122 (21): 1303.
https://doi.org/10.1182/blood.V122.21.1303.1303
Published: 2013
Journal Articles

Evaluation Of Myeloablative Therapy Followed By Autologous Stem Cell Transplantation In First Remission In Patients With Advanced Stage Follicular Lymphoma After Initial Immuno-Chemotherapy (R-CHOP) Or Chemotherapy Alone: Analysis Of 940 Patients Treated In Prospective Randomized Trials Of The German Low Grade Lymphoma Study Group (GLSG)

Wolfgang Hiddemann, M.D., Martin H. Dreyling, M.D. Ph.D., Bernd Metzner, M.D., Michael Pfreundschuh, M.D. Ph.D., Martin Wilhelm, M.D. Ph.D., Eva Lengfelder, M.D. Ph.D., Georg Hess, M.D. Ph.D., Michael Hallek, M.D. Ph.D., Norbert Schmitz, M.D. Ph.D., Christiane Pott, M.D. Ph.D., Thomas Fischer, M.D. Ph.D., Roswitha Forstpointner, M.D., Eva Hoster, Ph.D., Michael Unterhalt, M.D. Ph.D.
Journal: Blood
Blood (2013) 122 (21): 419.
https://doi.org/10.1182/blood.V122.21.419.419
Published: 2013
Journal Articles

High Efficacy and Significantly Shortened Neutropenia Of Dose-Dense S-HAM As Compared To Standard Double Induction: First Results Of a Prospective Randomized Trial (AML-CG 2008)

Jan Braess, MD, Karl-Anton Kreuzer, Karsten Spiekermann, PhD, Hans Walter Lindemann, MD, Eva Lengfelder, MD, Ullrich Graeven, Peter Staib, MD, Wolf-Dieter Ludwig, Harald Biersack, Yon-Dschun Ko, MD, Michael J. Uppenkamp, Stefan Korsten, Maike De Wit, Rudolf Peceny, MD, Tobias Gaska, MD, Xaver Schiel, Dirk M Behringer, MD, Michael G. Kiehl, MD, PhD, Bettina Zinngrebe, Gerald Meckenstock, Eva Roemer, Dirk Medgenberg, Ernst Spaeth-Schwalbe, MD, Birgit Braess, MD, Gero Massenkeil, MD, Heidrun Hindahl, Guido Trenn, Rainer Schwerdtfeger, MD, Susanne Amler, MSc, Cristina Sauerland, MSc, Andreas Faldum, MD, Michael Unterhalt, M.D. Ph.D., Stefan K. Bohlander, MD, Stephanie Schneider, PhD, Annika Dufour, PhD, Christian Buske, MD, Michael Fiegl, MD, Marion Subklewe, MD, Anja Baumgartner, PhD, Bernhard J. Woermann, MD, Dietrich Beelen, MD, Wolfgang Hiddemann, MD
Journal: Blood
Blood (2013) 122 (21): 619.
https://doi.org/10.1182/blood.V122.21.619.619
Published: 2013
Journal Articles

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Wolfgang Kern, M.D., Hubert Serve, M.D., Peter Staib, M.D., Christa Kerschgens, M.D., Anett Matylis, M.D., Karin Tischmann, M.D., Christoph Huber, M.D., Wolf D. Hirschmann, M.D., Hartmut Eimermacher, M.D., Johann G. Lange, M.D., Anke Zumsprekerl, M.D., Georg Maschmeyer, M.D., Michael Unterhalt, M.D., Jörn Ohnesorge, Maria C. Sauerland, Wolfgang Berdel, M.D., Thomas Büchner, M.D., Torsten Haferlach, M.D., Claudia Schoch, M.D., Wolf D. Ludwig, M.D., Wolfgang Hiddemann, M.D.
Journal: Blood
Blood (2004) 104 (11): 871.
https://doi.org/10.1182/blood.V104.11.871.871
Published: 2004